High‐Content SRS Imaging Unveils Altered Cholesterol Metabolism in Ovarian Cancers Under CAR‐T Treatment
Advanced Science · 2026
DOI: 10.1002/advs.202518334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chinmayee V Prabhu Dessai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cholesterol, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Foundation for the National Institutes of Health, NIGMS NIH HHS.
Abstract (Originalsprache)
Ovarian cancer is one of the most lethal gynecological cancers worldwide and has one of the highest recurrence rates. Recently developed Chimeric Antigen Receptor (CAR) ‐T cell therapy has shown potent clinical efficacy against hematological malignancies. However, solid tumors, including ovarian cancer, possess several mechanisms that hinder T cell activity, and metabolic alteration of cancer cells has been shown to contribute to resistance to immune cell attack against solid tumors. Here, we explore the metabolic response of ovarian cancer cells to CAR‐T cell attack using label‐free high‐content hyperspectral stimulated Raman scattering (h 2 SRS) imaging. Utilizing visible h 2 SRS imaging with much improved spatial resolution, we find an altered cholesterol metabolism, featured by increased storage of cholesteryl ester in lipid droplets and free cholesterol, in ovarian cancer cells that survive the CAR‐T treatment. Administration of Avasimibe, an inhibitor of cholesteryl esterification, further enhances CAR‐T cytotoxicity. Our study shows the promise of implementing metabolic modulation to facilitate CAR‐T cell treatment of solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
- Photonics Center, Boston University, Boston, Massachusetts, USA.
- Biological Design Center, Boston University, Boston, Massachusetts, USA.
- Department of Electrical and Computer Engineering, Boston University, Boston, Massachusetts, USA.
ORCID-Profile: Chinmayee V Prabhu Dessai, Ji-Xin Cheng
Förderung
- NIH HHS
- Foundation for the National Institutes of Health
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Prabhu Dessai, C. V., Huang, Z., Lin, H., Ding, G., He, H., Siddiqui, M., Zhang, M., Wong, W., & Cheng, J. X. (2026). High‐Content SRS Imaging Unveils Altered Cholesterol Metabolism in Ovarian Cancers Under CAR‐T Treatment. Advanced Science. https://doi.org/10.1002/advs.202518334
Vancouver
Prabhu Dessai CV, Huang Z, Lin H, Ding G, He H, Siddiqui M, et al. High‐Content SRS Imaging Unveils Altered Cholesterol Metabolism in Ovarian Cancers Under CAR‐T Treatment. Advanced Science. 2026. doi:10.1002/advs.202518334
BibTeX
@article{PrabhuDessai2026,
author = {Prabhu Dessai, Chinmayee V and Huang, Zhuoying and Lin, Haonan and Ding, Guangrui and He, Hongjian and Siddiqui, Menna and Zhang, Meng and Wong, Wilson and Cheng, Ji-Xin},
title = {High‐Content SRS Imaging Unveils Altered Cholesterol Metabolism in Ovarian Cancers Under CAR‐T Treatment},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202518334}
}
EUVIMED